Is a complete REPL research report available?

No complete published report is available for Replimune Group, Inc. (REPL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Replimune Group, Inc. (REPL)

NASDAQ: REPL · USD

$15.9

+2.85 (+21.8%)· Recorded snapshot

Market cap	1.5B
Net income (ttm)	-271M
EPS (ttm)	-$2.79
Shares out	94.2M
Volume	6,769,683
Beta	0.94

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -271M
EPS (ttm): -$2.79
Market cap: 1.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001737953
Company name	Replimune Group, Inc.
Country	United States
Country code	US
CUSIP number	76029N106
Earnings date	2026-10-28
Earnings time	bmo
Employees	465
Employees change	-14
Employees growth	-2.92%
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	March
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2018-07-20
Is primary listing	Yes
Is SPAC	No
ISIN number	US76029N1063
Last 10-K release date	2026-06-29
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.5B
Market cap category	Small-Cap
Next earnings date	2027-02-02
Options	Yes
Price	$15.90
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	REPL
U.S. state	Massachusetts
Website	https://www.replimune.com

Metric

Value

Amount currency

USD

CIK code

0001737953

Company name

Replimune Group, Inc.

Country

United States

Country code

CUSIP number

76029N106

Earnings date

2026-10-28

Earnings time

bmo

Employees

465

Employees change

-14

Employees growth

-2.92%

Enterprise value

$1.3B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-09

Fiscal year end

March

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2018-07-20

Is primary listing

Yes

Is SPAC

ISIN number

US76029N1063

Last 10-K release date

2026-06-29

Last earnings date

2026-10-28

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.5B

Market cap category

Small-Cap

Next earnings date

2027-02-02

Options

Yes

Price

$15.90

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

REPL

U.S. state

Massachusetts

Website

https://www.replimune.com

Metric	Value
Earnings yield	-17.52%
FCF / EV yield	-22.42%
FCF yield	-19.25%
Forward EV/Sales	19.95x
Forward P/S	23.24x
P/B ratio	10.37x
Price / tangible book value	6.23x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-17.52%

FCF / EV yield

-22.42%

FCF yield

-19.25%

Forward EV/Sales

19.95x

Forward P/S

23.24x

P/B ratio

10.37x

Price / tangible book value

6.23x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-582,869
ROA	-43.95%
ROA (5Y)	-27.19%
ROCE	-81.73%
ROE	-115.8%
ROE (5Y)	-55.78%
ROIC	-49.95%

Metric

Value

Profit per employee

$-582,869

ROA

-43.95%

ROA (5Y)

-27.19%

ROCE

-81.73%

ROE

-115.8%

ROE (5Y)

-55.78%

ROIC

-49.95%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-223,000
Depreciation and amortization	$5.8M
EBIT	$-268.4M
EBITDA	$-262.6M
EPS	$-2.79
FCF per share	$-2.61
Financing cash flow	$227.5M
Free cash flow	$-245.8M
Free cash flow minus SBC	$-279.2M
Income taxes	$-551,000
Investing cash flow	$221.4M
Net borrowing	$49.2M
Net cash flow	$205.5M
Net income	$-271M
Operating cash flow minus SBC	$-278.9M
Operating income	$-268.4M
Stock-based compensation	$33.4M

Metric

Value

Capital expenditures

$-223,000

Depreciation and amortization

$5.8M

EBIT

$-268.4M

EBITDA

$-262.6M

EPS

$-2.79

FCF per share

$-2.61

Financing cash flow

$227.5M

Free cash flow

$-245.8M

Free cash flow minus SBC

$-279.2M

Income taxes

$-551,000

Investing cash flow

$221.4M

Net borrowing

$49.2M

Net cash flow

$205.5M

Net income

$-271M

Operating cash flow minus SBC

$-278.9M

Operating income

$-268.4M

Stock-based compensation

$33.4M

Metric	Value
Book value per share	$2.16
Debt / equity	0.62
Interest coverage	-24.47
Long-term assets	$49.9M
Long-term liabilities	$123.6M
Net cash (debt)	$180.6M
Net cash / market cap	14.15%
Net cash growth	-26.96%
Net debt / equity	-0.88
Piotroski F-Score	2
Property, plant and equipment	$44.7M
Shareholders' equity	$204.8M
Tangible book value	$204.8M
Tangible book value per share	$2.16
Total assets	$373.9M
Total cash	$307.8M
Total debt	$127.2M
Total liabilities	$169.2M
WACC	9.17%

Metric

Value

Book value per share

$2.16

Debt / equity

0.62

Interest coverage

-24.47

Long-term assets

$49.9M

Long-term liabilities

$123.6M

Net cash (debt)

$180.6M

Net cash / market cap

14.15%

Net cash growth

-26.96%

Net debt / equity

-0.88

Piotroski F-Score

Property, plant and equipment

$44.7M

Shareholders' equity

$204.8M

Tangible book value

$204.8M

Tangible book value per share

$2.16

Total assets

$373.9M

Total cash

$307.8M

Total debt

$127.2M

Total liabilities

$169.2M

WACC

9.17%

Metric	Value
Current assets	$324M
Current liabilities	$45.6M
Current ratio	7.11
Net working capital	$-25.3M
Quick ratio	6.76
Working capital	$278.5M

Metric

Value

Current assets

$324M

Current liabilities

$45.6M

Current ratio

7.11

Net working capital

$-25.3M

Quick ratio

6.76

Working capital

$278.5M

Metric	Value
Buyback yield / dilution	-8.94%
Dividend yield	0%
Shareholder yield	-8.94%

Metric

Value

Buyback yield / dilution

-8.94%

Dividend yield

Shareholder yield

-8.94%

Metric	Value
150-day SMA	$9.76
1D price change	21.84%
1M price change	30.18%
1M total return	30.18%
1W price change	40.89%
1W total return	40.89%
1Y price change	72.45%
1Y return CAGR	72.52%
1Y total return	72.45%
20-day SMA	$12.55
200-day SMA	$9.21
3M price change	86.44%
3M total return	86.44%
3Y price change	18.48%
3Y return CAGR	5.82%
3Y total return	18.48%
50-day SMA	$13.46
50-day SMA vs 200-day SMA	50over200
52-week high	$16.75
52-week high date	2026-10-28
52-week low	$1.50
52-week low date	2026-04-13
5Y price change	-43.64%
5Y return CAGR	-10.84%
5Y total return	-43.64%
6M price change	500.37%
6M total return	500.37%
All-time high	$54.85
All-time high date	2020-11-19
All-time low	$1.50
All-time low date	2026-04-13
Average true range (ATR)	$1.04
Average volume	2.1M
Beta (1Y)	0.18
Beta (2Y)	0.38
Beta (5Y)	0.94
Change from 52-week high	-5.07%
Change from 52-week low	960%
Change from all-time high	-70.67%
Change from all-time low	972.67%
Change from open	23.16%
Day's gap	-1.07%
Dollar volume	$107.6M
High price	$16.71
Low price	$12.62
Monthly RSI	59.14
Open price	$12.91
Position in 52-week range	80.2%
Premarket change	-1.23%
Premarket close	$13.05
Premarket price	$12.89
Premarket volume	10.1K
Previous close	$13.05
Price vs 150-day SMA	64.84%
Price vs 20-day SMA	28.21%
Price vs 200-day SMA	74.68%
Price vs 50-day SMA	19.56%
Relative volume	3.19
RSI	70.42
Sharpe ratio	1.15
Sharpe ratio (3Y)	0.79
Sharpe ratio (5Y)	0.52
Sortino ratio	2.31
Sortino ratio (3Y)	1.47
Sortino ratio (5Y)	0.97
Volume	6.8M
Weekly RSI	63.97
YTD price change	65.54%
YTD total return	65.54%

Metric

Value

150-day SMA

$9.76

1D price change

21.84%

1M price change

30.18%

1M total return

30.18%

1W price change

40.89%

1W total return

40.89%

1Y price change

72.45%

1Y return CAGR

72.52%

1Y total return

72.45%

20-day SMA

$12.55

200-day SMA

$9.21

3M price change

86.44%

3M total return

86.44%

3Y price change

18.48%

3Y return CAGR

5.82%

3Y total return

18.48%

50-day SMA

$13.46

50-day SMA vs 200-day SMA

50over200

52-week high

$16.75

52-week high date

2026-10-28

52-week low

$1.50

52-week low date

2026-04-13

5Y price change

-43.64%

5Y return CAGR

-10.84%

5Y total return

-43.64%

6M price change

500.37%

6M total return

500.37%

All-time high

$54.85

All-time high date

2020-11-19

All-time low

$1.50

All-time low date

2026-04-13

Average true range (ATR)

$1.04

Average volume

2.1M

Beta (1Y)

0.18

Beta (2Y)

0.38

Beta (5Y)

0.94

Change from 52-week high

-5.07%

Change from 52-week low

960%

Change from all-time high

-70.67%

Change from all-time low

972.67%

Change from open

23.16%

Day's gap

-1.07%

Dollar volume

$107.6M

High price

$16.71

Low price

$12.62

Monthly RSI

59.14

Open price

$12.91

Position in 52-week range

80.2%

Premarket change

-1.23%

Premarket close

$13.05

Premarket price

$12.89

Premarket volume

10.1K

Previous close

$13.05

Price vs 150-day SMA

64.84%

Price vs 20-day SMA

28.21%

Price vs 200-day SMA

74.68%

Price vs 50-day SMA

19.56%

Relative volume

3.19

RSI

70.42

Sharpe ratio

1.15

Sharpe ratio (3Y)

0.79

Sharpe ratio (5Y)

0.52

Sortino ratio

2.31

Sortino ratio (3Y)

1.47

Sortino ratio (5Y)

0.97

Volume

6.8M

Weekly RSI

63.97

YTD price change

65.54%

YTD total return

65.54%

Metric	Value
Float	67.7M
Float percentage	71.8%
Shares change (QoQ)	8.58%
Shares change (YoY)	8.94%
Shares held by insiders	1.59%
Shares held by institutions	77.68%
Shares outstanding	94.2M
Short % of float	34.19%
Short % of shares	24.55%
Short ratio	11 days

Metric

Value

Float

67.7M

Float percentage

71.8%

Shares change (QoQ)

8.58%

Shares change (YoY)

8.94%

Shares held by insiders

1.59%

Shares held by institutions

77.68%

Shares outstanding

94.2M

Short % of float

34.19%

Short % of shares

24.55%

Short ratio

11 days

Replimune Group, Inc. (REPL)

Price

Financial snapshot

Fair-value bridge

Latest news · REPL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All REPL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on REPL

Frequently asked questions